AI-CVD vs VX1
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your primary goal is to leverage existing CT scan data for opportunistic screening and early detection of cardiovascular and multisystem diseases. This platform is ideal for identifying hidden health risks, such as coronary artery calcium or cardiac chamber abnormalities, without requiring additional imaging, radiation, or disrupting current clinical workflows.
View AI-CVD →Choose VX1 if…
Choose VX1 if you are an electrophysiologist seeking real-time AI guidance during atrial fibrillation and atrial tachycardia ablation procedures. This software is specifically designed to assist in identifying dispersed electrograms during live interventions, aiming to reduce inter-operator variability and standardize procedural outcomes.
View VX1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AI-CVDAI-CVD integrates seamlessly into existing radiology workflows by performing opportunistic screening using already acquired CT scans, requiring no additional imaging or workflow disruption. This passive integration minimizes the burden on clinical staff. While VX1 offers a simple user interface and compatibility with existing EP systems for real-time assistance, it still requires active engagement during a complex interventional procedure.
Clinical Value
VX1Both tools are FDA-cleared and offer significant clinical value. AI-CVD provides broad, early detection and risk stratification for cardiovascular and multisystem diseases from existing CT scans. However, VX1 directly addresses a critical need in atrial fibrillation ablation by providing real-time AI guidance to identify dispersed electrograms, which has been shown to standardize outcomes and achieve high rates of freedom from AF/AT in clinical trials.
Pricing & Value
TieBoth AI-CVD and VX1 state 'contact for pricing,' and no public information regarding their specific pricing models, cost-effectiveness studies, or reimbursement pathways was found. Without transparent pricing or comparative value analyses, it is not possible to determine a winner in this dimension.
Enterprise Readiness
AI-CVDAI-CVD's cloud deployment model inherently offers scalability and easier management for enterprise environments. Furthermore, HeartLung Corporation's privacy policy explicitly details HIPAA-compliant security practices, including encrypted data transmission and secure cloud infrastructure, and states they 'may operate as a HIPAA Business Associate.' VX1's integration with existing EP systems is beneficial, but its enterprise readiness regarding explicit BAA and HIPAA compliance statements is less detailed in the available information.
Innovation
VX1While AI-CVD is innovative in leveraging existing CT scans for opportunistic screening, VX1 represents a more significant leap in real-time interventional cardiology. It is the 'first FDA cleared AI-based tool in interventional cardiac electrophysiology', providing active AI guidance during complex, high-stakes ablation procedures to standardize outcomes and reduce operator variability.
Support & Docs
VX1VX1 explicitly mentions the availability of a 'User Manual' and 'Brochure' on its product page, indicating readily accessible documentation for users. While HeartLung's privacy policy mentions 'customer support systems', no specific details about publicly available documentation or support resources for AI-CVD were found.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | VX1 |
|---|---|---|
| Tool Name | AI-CVD | VX1 |
| Company | HeartLung Corporation | Volta Medical |
| Primary Use Case | Opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. | Assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. |
| Target Specialties | Cardiology, Pulmonology, Radiology | Cardiology |
| Key AI Functionality | Automated CT-derived anatomical and density-based measurements for opportunistic screening, including Coronary Artery Calcium (CAC) scoring, valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, and aorta/pulmonary artery sizing. | AI-guided real-time identification of dispersed electrograms (EGMs) during AFib and atrial tachycardia ablation procedures, analyzing 3D anatomical and electrical maps. |
| Input Data/Modality | Existing chest and abdominal CT scans | Electrograms (EGMs) and 3D anatomical/electrical maps from EP lab systems |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and VX1.